Impact of HIV on Lung Cancer Outcomes
Author Information
Author(s): Powles T, Thirwell C, Newsom-Davis T, Nelson M, Shah P, Cox S, Gazzard B, Bower M
Primary Institution: Chelsea & Westminster Hospital
Hypothesis
Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART?
Conclusion
The survival of HIV-positive patients with advanced non-small-cell lung cancer is now similar to that of HIV-negative patients, suggesting improved outcomes due to HAART.
Supporting Evidence
- HIV is associated with a small, but significant risk of developing lung cancer.
- Before HAART, HIV-related NSCLC patients had worse outcomes compared to HIV-negative controls.
- The introduction of HAART has improved the life expectancy of HIV patients.
Takeaway
This study found that people with HIV and lung cancer can do just as well as those without HIV if they get the same treatment.
Methodology
The study compared treatment and outcomes of HIV-positive and age-matched HIV-negative patients with advanced NSCLC using a single-centre lung cancer database.
Potential Biases
Potential bias due to the retrospective nature of the data collection.
Limitations
The study is limited by its small sample size and the fact that it is a single-centre study.
Participant Demographics
9 HIV-positive patients and 27 HIV-negative controls, median ages 45 and 48 years respectively.
Statistical Information
P-Value
0.57
Confidence Interval
95% Confidence Interval: 4.2–4.8
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website